Dimitri Shcherbakov

609 total citations
23 papers, 425 citations indexed

About

Dimitri Shcherbakov is a scholar working on Molecular Biology, Organic Chemistry and Pharmacology. According to data from OpenAlex, Dimitri Shcherbakov has authored 23 papers receiving a total of 425 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 5 papers in Organic Chemistry and 5 papers in Pharmacology. Recurrent topics in Dimitri Shcherbakov's work include RNA and protein synthesis mechanisms (13 papers), Microbial Natural Products and Biosynthesis (5 papers) and Mitochondrial Function and Pathology (5 papers). Dimitri Shcherbakov is often cited by papers focused on RNA and protein synthesis mechanisms (13 papers), Microbial Natural Products and Biosynthesis (5 papers) and Mitochondrial Function and Pathology (5 papers). Dimitri Shcherbakov collaborates with scholars based in Switzerland, United States and Germany. Dimitri Shcherbakov's co-authors include Erik C. Böttger, Andrea Vasella, David Crich, Sven N. Hobbie, Rashid Akbergenov, Stefan Duscha, Jochen Schacht, Youjin Teo, David P Wolfer and Takahiko Matsushita and has published in prestigious journals such as Journal of the American Chemical Society, International Journal of Molecular Sciences and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Dimitri Shcherbakov

23 papers receiving 421 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dimitri Shcherbakov Switzerland 14 288 115 71 52 45 23 425
Stefan Duscha Switzerland 11 336 1.2× 78 0.7× 93 1.3× 82 1.6× 57 1.3× 11 524
Kristopher G. Virga United States 11 401 1.4× 53 0.5× 37 0.5× 42 0.8× 51 1.1× 14 560
Konstantin Kazarian United States 8 146 0.5× 79 0.7× 39 0.5× 120 2.3× 41 0.9× 11 415
Alvin C. Y. Kuk United States 7 208 0.7× 45 0.4× 32 0.5× 18 0.3× 24 0.5× 7 308
Irene G. Salado Spain 9 176 0.6× 83 0.7× 13 0.2× 22 0.4× 62 1.4× 14 359
Richa Rawat United States 8 327 1.1× 88 0.8× 75 1.1× 182 3.5× 64 1.4× 10 551
Michael Hoffmann Germany 17 490 1.7× 49 0.4× 31 0.4× 11 0.2× 88 2.0× 40 725
Jessica L. Schneck United States 11 263 0.9× 61 0.5× 24 0.3× 13 0.3× 66 1.5× 22 405
John M. Neu Canada 9 330 1.1× 100 0.9× 52 0.7× 80 1.5× 262 5.8× 10 520
Shu-Rui Li China 13 275 1.0× 88 0.8× 35 0.5× 21 0.4× 16 0.4× 17 533

Countries citing papers authored by Dimitri Shcherbakov

Since Specialization
Citations

This map shows the geographic impact of Dimitri Shcherbakov's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dimitri Shcherbakov with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dimitri Shcherbakov more than expected).

Fields of papers citing papers by Dimitri Shcherbakov

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dimitri Shcherbakov. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dimitri Shcherbakov. The network helps show where Dimitri Shcherbakov may publish in the future.

Co-authorship network of co-authors of Dimitri Shcherbakov

This figure shows the co-authorship network connecting the top 25 collaborators of Dimitri Shcherbakov. A scholar is included among the top collaborators of Dimitri Shcherbakov based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dimitri Shcherbakov. Dimitri Shcherbakov is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cuénod, Aline, Helena M. B. Seth-Smith, Tim Roloff, et al.. (2023). Bacterial genome-wide association study substantiates papGII of Escherichia coli as a major risk factor for urosepsis. Genome Medicine. 15(1). 89–89. 11 indexed citations
2.
Moore, James M., Claudia Keller, Amandine Grimm, et al.. (2022). Error-prone protein synthesis recapitulates early symptoms of Alzheimer disease in aging mice. Cell Reports. 40(13). 111433–111433. 17 indexed citations
3.
Koch, Philipp, Steven Schmitt, Dimitri Shcherbakov, et al.. (2022). Optimization of the antimicrobial peptide Bac7 by deep mutational scanning. BMC Biology. 20(1). 114–114. 17 indexed citations
4.
Shcherbakov, Dimitri, Rashid Akbergenov, Amandine Grimm, et al.. (2022). Premature aging in mice with error-prone protein synthesis. Science Advances. 8(9). eabl9051–eabl9051. 37 indexed citations
5.
Dharuman, Suresh, Jiuyu Liu, Stephanie M. Reeve, et al.. (2021). Synthesis, antibacterial action, and ribosome inhibition of deoxyspectinomycins. The Journal of Antibiotics. 74(6). 381–396. 8 indexed citations
6.
Moore, James M., Rashid Akbergenov, Amandine Grimm, et al.. (2021). Random errors in protein synthesis activate an age-dependent program of muscle atrophy in mice. Communications Biology. 4(1). 703–703. 9 indexed citations
7.
Mateos, José Marı́a, et al.. (2021). ER-misfolded proteins become sequestered with mitochondria and impair mitochondrial function. Communications Biology. 4(1). 1350–1350. 24 indexed citations
8.
Shcherbakov, Dimitri, Stefan Duscha, Lisa Michelle Restelli, et al.. (2020). Mitochondrial misreading in skeletal muscle accelerates metabolic aging and confers lipid accumulation and increased inflammation. RNA. 27(3). 265–272. 13 indexed citations
9.
Nečas, Marek, Dimitri Shcherbakov, Erik C. Böttger, et al.. (2020). Stereocontrolled Synthesis of (−)-Bactobolin A. Journal of the American Chemical Society. 142(16). 7306–7311. 14 indexed citations
10.
Matsushita, Takahiko, Takayuki Kato, Malgorzata Dobosz-Bartoszek, et al.. (2019). Design, Multigram Synthesis, and in Vitro and in Vivo Evaluation of Propylamycin: A Semisynthetic 4,5-Deoxystreptamine Class Aminoglycoside for the Treatment of Drug-Resistant Enterobacteriaceae and Other Gram-Negative Pathogens. Journal of the American Chemical Society. 141(12). 5051–5061. 45 indexed citations
11.
Sonousi, Amr, Dimitri Shcherbakov, Andrea Vasella, Erik C. Böttger, & David Crich. (2019). Synthesis, ribosomal selectivity, and antibacterial activity of netilmicin 4′-derivatives. MedChemComm. 10(6). 946–950. 3 indexed citations
12.
Sonousi, Amr, Klara Haldimann, Qiaojun Fang, et al.. (2019). Apralogs: Apramycin 5-O-Glycosides and Ethers with Improved Antibacterial Activity and Ribosomal Selectivity and Reduced Susceptibility to the Aminoacyltransferase (3)-IV Resistance Determinant. Journal of the American Chemical Society. 142(1). 530–544. 31 indexed citations
13.
Akbergenov, Rashid, Stefan Duscha, Naoki Oishi, et al.. (2018). Mutant MRPS 5 affects mitoribosomal accuracy and confers stress‐related behavioral alterations. EMBO Reports. 19(11). 32 indexed citations
14.
Shcherbakov, Dimitri, et al.. (2017). N6′, N6′′′, and O4′ Modifications to Neomycin Affect Ribosomal Selectivity without Compromising Antibacterial Activity. ACS Infectious Diseases. 3(5). 368–377. 13 indexed citations
15.
Yang, Guanyu, Takayuki Kato, Dimitri Shcherbakov, et al.. (2017). Structure-Based Design and Synthesis of Apramycin–Paromomycin Analogues: Importance of the Configuration at the 6′-Position and Differences between the 6′-Amino and Hydroxy Series. Journal of the American Chemical Society. 139(41). 14611–14619. 31 indexed citations
16.
Bruhn, David F., Samanthi L. Waidyarachchi, Dimitri Shcherbakov, et al.. (2015). Aminomethyl spectinomycins as therapeutics for drug-resistant respiratory tract and sexually transmitted bacterial infections. Science Translational Medicine. 7(288). 288ra75–288ra75. 15 indexed citations
17.
Matsushita, Takahiko, Weiwei Chen, Youjin Teo, et al.. (2015). Influence of 4′-O-Glycoside Constitution and Configuration on Ribosomal Selectivity of Paromomycin. Journal of the American Chemical Society. 137(24). 7706–7717. 22 indexed citations
18.
Shcherbakov, Dimitri, et al.. (2014). Importance of the 6′‐Hydroxy Group and Its Configuration for Apramycin Activity. ChemMedChem. 9(9). 2074–2083. 24 indexed citations
19.
Duscha, Stefan, Dimitri Shcherbakov, Sandrina Silva, et al.. (2014). Identification and Evaluation of Improved 4′-O-(Alkyl) 4,5-Disubstituted 2-Deoxystreptamines as Next-Generation Aminoglycoside Antibiotics. mBio. 5(5). e01827–14. 36 indexed citations
20.
Subramanian, Akshay, et al.. (2011). Phylogenetic Sequence Variations in Bacterial rRNA Affect Species-Specific Susceptibility to Drugs Targeting Protein Synthesis. Antimicrobial Agents and Chemotherapy. 55(9). 4096–4102. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Stefan Duscha Breakdown of academic impact, for papers by Kristopher G. Virga Breakdown of academic impact, for papers by Konstantin Kazarian Breakdown of academic impact, for papers by Alvin C. Y. Kuk Breakdown of academic impact, for papers by Irene G. Salado Breakdown of academic impact, for papers by Richa Rawat Breakdown of academic impact, for papers by Michael Hoffmann Breakdown of academic impact, for papers by Jessica L. Schneck Breakdown of academic impact, for papers by John M. Neu Breakdown of academic impact, for papers by Shu-Rui Li
Rankless by CCL
2026